83P Impact of treatment duration of extended adjuvant therapy with neratinib in early stage HER2+ HR+ breast cancer after trastuzumab-based therapy on patient outcomes
Research output: Contribution to journal › Conference abstract in journal › Research › peer-review
| Original language | English |
|---|---|
| Journal | Annals of Oncology |
| Volume | 31 |
| Issue number | S2 |
| Pages (from-to) | S43 |
| Number of pages | 1 |
| ISSN | 0923-7534 |
| DOIs | |
| Publication status | Published - 1 May 2020 |
ID: 269603991